SlideShare a Scribd company logo
1 of 31
Drugs Affecting the Male 
Reproductive System 
Chapter 41 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs Used to Affect the Male 
Reproductive System 
• Male Steroid Hormones or Androgens 
– Act like testosterone 
– Development of male sexual characteristics 
• Male Sex Hormone or Anabolic Steroids 
– Synthetic testosterone preparations that have more 
anabolic effects than androgenic effects 
– Tissue building 
• Drugs to Improve Penile Dysfunction 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sites of Action for Drugs Affecting the 
Male Reproductive System 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Signs and Symptoms of Adverse Effects of 
Androgens/Anabolic Steroids 
• Swelling in fingers or legs 
• Continual erection 
• Uncontrollable sex drive 
• Yellowing skin 
• Fever, chills, or rash 
• Chest pain or difficulty breathing 
• Hoarseness 
• Loss of hair or growth of facial hair in women 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Androgens and Their Indications 
• Testosterone (Duratest, Testoderm, others) 
– Hypogonadism; breast cancer 
• Danazol (Danocrine) 
– Block the release of FSH and LH in women 
• Fluoxymesterone (Halotestin) 
– Hypogonadism; breast cancer 
• Testolactone (Teslac) 
– Breast cancers 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Androgens 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Increase the retention of nitrogen, sodium, 
potassium 
– Decrease the urinary excretion of calcium 
– Increase protein anabolism 
– Decrease protein catabolism 
– Increase the production of red blood cells
Androgens (cont.) 
• Pharmacokinetics 
– Well absorbed and widely distributed throughout the 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
body 
– Metabolized in the liver and excreted in the urine 
• Contraindications 
– Allergy 
– Pregnancy and lactation 
– Prostate or breast cancer in men
Androgens (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Caution 
– Liver dysfunction or cardiovascular disease 
• Indications 
– Replacement therapy in hypogonadism and delayed 
puberty in males 
– Inoperable breast cancer 
– Prevention of ovulation to treat endometriosis 
• Adverse Effects 
– Acne, edema, hirsutism 
– Deepening of the voice, oily skin and hair, weight gain, 
decreased breast size, testicular atrophy
Androgens (cont.) 
• Adverse Effects (cont.) 
– Flushing sweating, vaginitis, nervousness, and 
emotional labiality 
– Headache, dizziness, sleep disorders, and altered 
electrolytes 
• Drug Laboratory Test 
– Thyroid function 
– Creatinine 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Alternative Therapies Used to Enhance 
Athletic Performance 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
Please answer the following statement as true or false. 
Androgens are male sex hormones and include 
testosterone produced in the testes, and the androgens 
which are produced in the posterior pituitary gland. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
False 
Rationale: Androgens are male sex hormones and include 
testosterone produced in the testes, and the androgens 
produced in the adrenal glands. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anabolic Steroids and Their Indications 
• Oxandrolone (Oxandrin) 
– Promote weight gain in debilitated patients 
– Increase protein anabolism 
– Treat certain cancers 
• Oxymetholone (Anadrol-50) 
– Treat various anemias 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anabolic Steroids 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Promote body tissue-building processes 
– Reverse catabolic or tissue-destroying processes 
– Increase hemoglobin and red blood cell mass 
• Indications 
– Indications vary with each drug 
– Treatment of anemias, certain cancers, and 
angioedema 
– Promote weight gain and tissue repair 
– Protein anabolism
Anabolic Steroids (cont.) 
• Pharmacokinetics 
– Well absorbed and widely distributed throughout the 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
body 
– Metabolized in the liver and excreted in the urine 
• Contraindications 
– Allergy and liver dysfunction 
– Pregnancy and lactation 
– Coronary disease 
– Prostate or breast cancer in males
Anabolic Steroids (cont.) 
• Adverse Effects 
– Cardiomyopathy 
– Hepatic carcinoma 
– Personality changes 
– Sexual dysfunction 
– Virilization 
– Inhibition or testicular function, gynecomastia, 
testicular atrophy, priapism, baldness, and change in 
libido 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anabolic Steroids (cont.) 
• Drug-to-Drug Interactions 
– Oral anticoagulants 
– Antidiabetic medications 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs Approved for the Treatment of 
Penile Erectile Dysfunction 
• Alprostadil (Caverject, MUSE) 
– Prostaglandin that relaxes vascular smooth muscle 
and allows filling of the corpus cavernosum when it is 
injected directly into the cavernosum 
• Sildenafil (Viagra), Tadalafil (Cialis), and Vardenafil 
(Levitra) 
– Selectively inhibits phosphodiesterase type 5 
receptors (PDE5) and increases nitrous oxide levels, 
allowing blood to flow into the corpus cavernosum 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drugs for Treatment of Penile Erectile 
Dysfunction 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Alprostadil: Injected and acts locally to relax vascular 
smooth muscle and promote blood flow into the corpus 
cavernosum causing penile erection. 
– Inhibits PDE5 receptors, leading to a release of nitrous 
oxide, which activates cGMP to cause a prolonged 
smooth muscle relaxation, allowing the flow of blood 
into the corpus cavernosum and facilitating erection. 
• Indications 
– Treatment of erectile dysfunction in the presence of 
sexual stimulation
Drugs for Treatment of Penile Erectile 
Dysfunction (cont.) 
• Pharmacokinetics 
– Well absorbed, metabolized in the liver and excreted in the 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
urine 
• Contraindications 
– Condition that might predispose to priapism 
– Penile implants 
– Use in women 
• Caution 
– Bleeding disorders, coronary artery disease, active peptic 
ulcer, retinitis pigmentosa, hypotension or severe 
hypertension, congenital prolonged Q T interval, or severe 
hepatic or renal disorders
Drugs for Treatment of Penile Erectile 
Dysfunction (cont.) 
• Adverse Effects 
– Edema, headache, dizziness, syncope, angina, 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
dyspnea 
• Drug-to-Drug Interactions 
– PDE5 inhibitors combined with organic nitrates or 
alpha blockers 
• Can cause dangerous cardiovascular effects, 
including death 
• Careful patient teaching is essential
Question 
After six months of use what is the mean dose of 
Caverject? 
A. 2.5 mcg 
B. 10.3 mcg 
C. 15.9 mcg 
D. 20.7 mcg 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
D. 20.7 mcg 
Rationale: Alprostadil (Caverject, MUSE): 2.5 mcg injected 
intracavernously, titrate the dose to one that will allow a 
satisfactory erection that is maintained no longer than 1 
hr; mean dose after 6 mo is reported to be 20.7 mcg. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Drugs Affecting the Male 
Reproductive System Across the Lifespan 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Androgen 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Androgen (Continued) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Anabolic Steroids 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Drugs for Treatment of Erectile 
Dysfunction 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Androgens 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Anabolic 
Steroids 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Drugs Used in 
the Treatment of Erectile Dysfunction 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58stanbridge
 
Ppt chapter 31-1
Ppt chapter 31-1Ppt chapter 31-1
Ppt chapter 31-1stanbridge
 
Ppt chapter 37-1
Ppt chapter 37-1Ppt chapter 37-1
Ppt chapter 37-1stanbridge
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18stanbridge
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34stanbridge
 
Reproductive System Drugs
Reproductive System DrugsReproductive System Drugs
Reproductive System DrugsTosca Torres
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Drug use in pregnancy
Drug use in pregnancy  Drug use in pregnancy
Drug use in pregnancy Htet Wai Moe
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38stanbridge
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1stanbridge
 
Ppt chapter 49
Ppt chapter 49Ppt chapter 49
Ppt chapter 49stanbridge
 
Endrocrine drugs
Endrocrine drugsEndrocrine drugs
Endrocrine drugsUmair hanif
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Drugs acting on the gastrointestinal tract
Drugs acting on the gastrointestinal tractDrugs acting on the gastrointestinal tract
Drugs acting on the gastrointestinal tractBruno Mmassy
 
Uterine stimulants & relaxants
Uterine stimulants & relaxantsUterine stimulants & relaxants
Uterine stimulants & relaxantsBikashAdhikari26
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28stanbridge
 

What's hot (20)

Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 31-1
Ppt chapter 31-1Ppt chapter 31-1
Ppt chapter 31-1
 
Ppt chapter 37-1
Ppt chapter 37-1Ppt chapter 37-1
Ppt chapter 37-1
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34
 
Reproductive System Drugs
Reproductive System DrugsReproductive System Drugs
Reproductive System Drugs
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Drug use in pregnancy
Drug use in pregnancy  Drug use in pregnancy
Drug use in pregnancy
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Ppt chapter 49
Ppt chapter 49Ppt chapter 49
Ppt chapter 49
 
Endrocrine drugs
Endrocrine drugsEndrocrine drugs
Endrocrine drugs
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Drugs acting on the gastrointestinal tract
Drugs acting on the gastrointestinal tractDrugs acting on the gastrointestinal tract
Drugs acting on the gastrointestinal tract
 
Endocrine drugs
Endocrine drugsEndocrine drugs
Endocrine drugs
 
Uterine stimulants & relaxants
Uterine stimulants & relaxantsUterine stimulants & relaxants
Uterine stimulants & relaxants
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28
 

Viewers also liked

Ppt chapter 20-1
Ppt chapter 20-1Ppt chapter 20-1
Ppt chapter 20-1stanbridge
 
Ppt chapter 29-1
Ppt chapter 29-1Ppt chapter 29-1
Ppt chapter 29-1stanbridge
 
Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51stanbridge
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50stanbridge
 
Week 5 Powerpoint Chapter 46
Week 5 Powerpoint Chapter 46Week 5 Powerpoint Chapter 46
Week 5 Powerpoint Chapter 46stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1stanbridge
 
Pharmacology powerpoint git drugs
Pharmacology powerpoint  git drugsPharmacology powerpoint  git drugs
Pharmacology powerpoint git drugsFred Ecaldre
 
Gastrointestinal System Disorders
Gastrointestinal System DisordersGastrointestinal System Disorders
Gastrointestinal System DisordersJessie Madz
 
Gastrointestinal physiology
Gastrointestinal physiologyGastrointestinal physiology
Gastrointestinal physiologyKern Rocke
 
What is Occupational Therapy? Inservice
What is Occupational Therapy? InserviceWhat is Occupational Therapy? Inservice
What is Occupational Therapy? Inservicestanbridge
 

Viewers also liked (17)

Ppt chapter 20-1
Ppt chapter 20-1Ppt chapter 20-1
Ppt chapter 20-1
 
Ppt chapter 29-1
Ppt chapter 29-1Ppt chapter 29-1
Ppt chapter 29-1
 
Chapter040
Chapter040Chapter040
Chapter040
 
Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt chapter 51
Ppt chapter 51Ppt chapter 51
Ppt chapter 51
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50
 
Week 5 Powerpoint Chapter 46
Week 5 Powerpoint Chapter 46Week 5 Powerpoint Chapter 46
Week 5 Powerpoint Chapter 46
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Medical surgical textbook
Medical surgical textbookMedical surgical textbook
Medical surgical textbook
 
Ppt chapter 51-1
Ppt chapter 51-1Ppt chapter 51-1
Ppt chapter 51-1
 
Pharmacology powerpoint git drugs
Pharmacology powerpoint  git drugsPharmacology powerpoint  git drugs
Pharmacology powerpoint git drugs
 
Gastrointestinal System Disorders
Gastrointestinal System DisordersGastrointestinal System Disorders
Gastrointestinal System Disorders
 
Gastrointestinal physiology
Gastrointestinal physiologyGastrointestinal physiology
Gastrointestinal physiology
 
What is Occupational Therapy? Inservice
What is Occupational Therapy? InserviceWhat is Occupational Therapy? Inservice
What is Occupational Therapy? Inservice
 

Similar to Drugs Affecting Male Repro: Androgens, ED Meds, Anabolics

Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1stanbridge
 
Ppt chapter 46
Ppt chapter 46Ppt chapter 46
Ppt chapter 46stanbridge
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47stanbridge
 
Ppt chapter 44
Ppt chapter 44Ppt chapter 44
Ppt chapter 44stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58stanbridge
 
Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1stanbridge
 
Ppt chapter 43
Ppt chapter 43Ppt chapter 43
Ppt chapter 43stanbridge
 
PPT_Chapter_22.ppt
PPT_Chapter_22.pptPPT_Chapter_22.ppt
PPT_Chapter_22.pptHillaryBell4
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Ppt chapter 33
Ppt chapter 33Ppt chapter 33
Ppt chapter 33stanbridge
 

Similar to Drugs Affecting Male Repro: Androgens, ED Meds, Anabolics (20)

Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1
 
Ppt chapter 46
Ppt chapter 46Ppt chapter 46
Ppt chapter 46
 
Ppt chapter 47
Ppt chapter 47Ppt chapter 47
Ppt chapter 47
 
Ppt chapter 44
Ppt chapter 44Ppt chapter 44
Ppt chapter 44
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1
 
Ppt chapter 43
Ppt chapter 43Ppt chapter 43
Ppt chapter 43
 
PPT_Chapter_22.ppt
PPT_Chapter_22.pptPPT_Chapter_22.ppt
PPT_Chapter_22.ppt
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Ppt chapter 33
Ppt chapter 33Ppt chapter 33
Ppt chapter 33
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Drugs Affecting Male Repro: Androgens, ED Meds, Anabolics

  • 1. Drugs Affecting the Male Reproductive System Chapter 41 Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Drugs Used to Affect the Male Reproductive System • Male Steroid Hormones or Androgens – Act like testosterone – Development of male sexual characteristics • Male Sex Hormone or Anabolic Steroids – Synthetic testosterone preparations that have more anabolic effects than androgenic effects – Tissue building • Drugs to Improve Penile Dysfunction Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 3. Sites of Action for Drugs Affecting the Male Reproductive System Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 4. Signs and Symptoms of Adverse Effects of Androgens/Anabolic Steroids • Swelling in fingers or legs • Continual erection • Uncontrollable sex drive • Yellowing skin • Fever, chills, or rash • Chest pain or difficulty breathing • Hoarseness • Loss of hair or growth of facial hair in women Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 5. Androgens and Their Indications • Testosterone (Duratest, Testoderm, others) – Hypogonadism; breast cancer • Danazol (Danocrine) – Block the release of FSH and LH in women • Fluoxymesterone (Halotestin) – Hypogonadism; breast cancer • Testolactone (Teslac) – Breast cancers Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Androgens Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Increase the retention of nitrogen, sodium, potassium – Decrease the urinary excretion of calcium – Increase protein anabolism – Decrease protein catabolism – Increase the production of red blood cells
  • 7. Androgens (cont.) • Pharmacokinetics – Well absorbed and widely distributed throughout the Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins body – Metabolized in the liver and excreted in the urine • Contraindications – Allergy – Pregnancy and lactation – Prostate or breast cancer in men
  • 8. Androgens (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Caution – Liver dysfunction or cardiovascular disease • Indications – Replacement therapy in hypogonadism and delayed puberty in males – Inoperable breast cancer – Prevention of ovulation to treat endometriosis • Adverse Effects – Acne, edema, hirsutism – Deepening of the voice, oily skin and hair, weight gain, decreased breast size, testicular atrophy
  • 9. Androgens (cont.) • Adverse Effects (cont.) – Flushing sweating, vaginitis, nervousness, and emotional labiality – Headache, dizziness, sleep disorders, and altered electrolytes • Drug Laboratory Test – Thyroid function – Creatinine Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 10. Alternative Therapies Used to Enhance Athletic Performance Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 11. Question Please answer the following statement as true or false. Androgens are male sex hormones and include testosterone produced in the testes, and the androgens which are produced in the posterior pituitary gland. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Answer False Rationale: Androgens are male sex hormones and include testosterone produced in the testes, and the androgens produced in the adrenal glands. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Anabolic Steroids and Their Indications • Oxandrolone (Oxandrin) – Promote weight gain in debilitated patients – Increase protein anabolism – Treat certain cancers • Oxymetholone (Anadrol-50) – Treat various anemias Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 14. Anabolic Steroids Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Promote body tissue-building processes – Reverse catabolic or tissue-destroying processes – Increase hemoglobin and red blood cell mass • Indications – Indications vary with each drug – Treatment of anemias, certain cancers, and angioedema – Promote weight gain and tissue repair – Protein anabolism
  • 15. Anabolic Steroids (cont.) • Pharmacokinetics – Well absorbed and widely distributed throughout the Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins body – Metabolized in the liver and excreted in the urine • Contraindications – Allergy and liver dysfunction – Pregnancy and lactation – Coronary disease – Prostate or breast cancer in males
  • 16. Anabolic Steroids (cont.) • Adverse Effects – Cardiomyopathy – Hepatic carcinoma – Personality changes – Sexual dysfunction – Virilization – Inhibition or testicular function, gynecomastia, testicular atrophy, priapism, baldness, and change in libido Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 17. Anabolic Steroids (cont.) • Drug-to-Drug Interactions – Oral anticoagulants – Antidiabetic medications Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Drugs Approved for the Treatment of Penile Erectile Dysfunction • Alprostadil (Caverject, MUSE) – Prostaglandin that relaxes vascular smooth muscle and allows filling of the corpus cavernosum when it is injected directly into the cavernosum • Sildenafil (Viagra), Tadalafil (Cialis), and Vardenafil (Levitra) – Selectively inhibits phosphodiesterase type 5 receptors (PDE5) and increases nitrous oxide levels, allowing blood to flow into the corpus cavernosum Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 19. Drugs for Treatment of Penile Erectile Dysfunction Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Alprostadil: Injected and acts locally to relax vascular smooth muscle and promote blood flow into the corpus cavernosum causing penile erection. – Inhibits PDE5 receptors, leading to a release of nitrous oxide, which activates cGMP to cause a prolonged smooth muscle relaxation, allowing the flow of blood into the corpus cavernosum and facilitating erection. • Indications – Treatment of erectile dysfunction in the presence of sexual stimulation
  • 20. Drugs for Treatment of Penile Erectile Dysfunction (cont.) • Pharmacokinetics – Well absorbed, metabolized in the liver and excreted in the Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins urine • Contraindications – Condition that might predispose to priapism – Penile implants – Use in women • Caution – Bleeding disorders, coronary artery disease, active peptic ulcer, retinitis pigmentosa, hypotension or severe hypertension, congenital prolonged Q T interval, or severe hepatic or renal disorders
  • 21. Drugs for Treatment of Penile Erectile Dysfunction (cont.) • Adverse Effects – Edema, headache, dizziness, syncope, angina, Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins dyspnea • Drug-to-Drug Interactions – PDE5 inhibitors combined with organic nitrates or alpha blockers • Can cause dangerous cardiovascular effects, including death • Careful patient teaching is essential
  • 22. Question After six months of use what is the mean dose of Caverject? A. 2.5 mcg B. 10.3 mcg C. 15.9 mcg D. 20.7 mcg Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Answer D. 20.7 mcg Rationale: Alprostadil (Caverject, MUSE): 2.5 mcg injected intracavernously, titrate the dose to one that will allow a satisfactory erection that is maintained no longer than 1 hr; mean dose after 6 mo is reported to be 20.7 mcg. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Use of Drugs Affecting the Male Reproductive System Across the Lifespan Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Prototype Androgen Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Prototype Androgen (Continued) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 27. Prototype Anabolic Steroids Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 28. Prototype Drugs for Treatment of Erectile Dysfunction Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Nursing Considerations for Androgens • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Nursing Considerations for Anabolic Steroids • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Nursing Considerations for Drugs Used in the Treatment of Erectile Dysfunction • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins